Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study(Oct, 10.1007/s40744-022-00498-x, 2022)

作者

推荐